104 related articles for article (PubMed ID: 6104132)
1. Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.
Netzel B; Haas RJ; Rodt H; Kolb HJ; Thierfelder S
Lancet; 1980 Jun; 1(8182):1330-2. PubMed ID: 6104132
[TBL] [Abstract][Full Text] [Related]
2. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF
Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation in leukemia.
Netzel B; Haas RI; Thierfelder S
Recent Results Cancer Res; 1984; 93():290-300. PubMed ID: 6382486
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone-marrow transplantation in relapsed adult acute leukaemia.
Dicke KA; Zander A; Spitzer G; Verma DS; Peters L; Vellekoop L; McCredie KB; Hester J
Lancet; 1979 Mar; 1(8115):514-7. PubMed ID: 85105
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H
Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307
[TBL] [Abstract][Full Text] [Related]
7. [Recent aspects on the use of specific antisera in diagnosis and therapy of acute lymphatic leukaemia in infants (author's transl)].
Netzel B; Rodt H; Thiel E; Haas RJ; Thierfelder S
Klin Padiatr; 1979 Mar; 191(2):175-81. PubMed ID: 376934
[TBL] [Abstract][Full Text] [Related]
8. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
[TBL] [Abstract][Full Text] [Related]
9. Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?
Odom LF; August CS; Githens JH; Humbert JR; Morse H; Peakman D; Sharma B; Rusnak SL; Johnson FB
Lancet; 1978 Sep; 2(8089):537-40. PubMed ID: 79913
[TBL] [Abstract][Full Text] [Related]
10. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
[No Abstract] [Full Text] [Related]
11. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure.
Ito T; Ishikawa Y; Noda M; Fujii R
Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
Champlin R; Gale RP
Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in acute leukaemia.
Gale RP; Champlin RE
Clin Haematol; 1986 Aug; 15(3):851-72. PubMed ID: 3536244
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow purging using monoclonal antibodies.
Ramsay NK; Kersey JH
J Clin Immunol; 1988 Mar; 8(2):81-8. PubMed ID: 3286676
[No Abstract] [Full Text] [Related]
16. Bone marrow transplantation for acute lymphoblastic leukaemia.
Barrett AJ; Kendra JR; Lucas CF; Joss DV; Joshi R; Desai M; Jones KH; Phillips RH; Rogers TR; Tabara Z; Williamson S; Hobbs JR
Br J Haematol; 1982 Oct; 52(2):181-8. PubMed ID: 6751376
[TBL] [Abstract][Full Text] [Related]
17. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
[TBL] [Abstract][Full Text] [Related]
18. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia.
Racadot E; Herve P; Lamy B; Peters A
Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
Niemeyer CM; Ritz J; Donahue K; Sallan SE
Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082
[No Abstract] [Full Text] [Related]
20. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
Barrett AJ; Joshi R; Tew C
Lancet; 1985 May; 1(8439):1188-91. PubMed ID: 2860389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
